Angiotech Pharmaceuticals

ANP-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about ANP-T

Signal
Opinion
Expert
TOP PICK
TOP PICK
August 24, 2001
Expects health services to lead the market. More angioplasty due to aging population.
Show full opinionHide full opinion
Expects health services to lead the market. More angioplasty due to aging population.
WAIT
WAIT
August 23, 2001
In competition with J & J on their stents. Expects a lot of news in trials during September.
Show full opinionHide full opinion
In competition with J & J on their stents. Expects a lot of news in trials during September.
DON'T BUY
DON'T BUY
July 3, 2001
Too speculative. Good balance sheet and lots of cash, but no earnings.
Show full opinionHide full opinion
Too speculative. Good balance sheet and lots of cash, but no earnings.
WAIT
WAIT
April 5, 2001
Wait for results on tests for coated stents.
Show full opinionHide full opinion
Wait for results on tests for coated stents.
TOP PICK
TOP PICK
April 3, 2001
Good biotech. Lots of cash. Have US producers. Excellent mngmnt
Show full opinionHide full opinion
Good biotech. Lots of cash. Have US producers. Excellent mngmnt
Showing 136 to 140 of 140 entries